Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
Condition(s):Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:January 2, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:January 2, 2020Completed
Condition(s):Recurrent Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin MelanomaLast Updated:July 22, 2022Terminated
Condition(s):Recurrent Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin MelanomaLast Updated:June 9, 2017Completed
Condition(s):Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin MelanomaLast Updated:April 5, 2018Withdrawn
Condition(s):Malignant MelanomaLast Updated:September 26, 2018Completed
Condition(s):Unresecable Stage IIIc or IV MelanomaLast Updated:June 12, 2018Completed
Condition(s):Acral Lentiginous Malignant Melanoma; Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:December 23, 2014Completed
Condition(s):Melanoma (Skin)Last Updated:September 26, 2017Completed
Condition(s):Melanoma (Skin)Last Updated:February 19, 2018Completed
Condition(s):Melanoma (Skin)Last Updated:January 18, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.